Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00641797 · ClinicalTrials.gov registry record · NA
Treating Benign Paroxysmal Positional Vertigo (BPPV) in ED Patients
A NA study of Benign Paroxysmal Positional Vertigo, sponsored by Lehigh Valley Hospital.
- Completed
- Registry status
- NA
- Development phase
- 26
- Enrollment target
- 1
- Study location
NCT00641797: Completed NA study of Benign Paroxysmal Positional Vertigo, sponsored by Lehigh Valley Hospital.
NCT00641797 is a NA study of Benign Paroxysmal Positional Vertigo that has completed, run by Lehigh Valley Hospital. The registered enrollment target is 26 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00641797, a NA study of Benign Paroxysmal Positional Vertigo, has completed, sponsored by Lehigh Valley Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
- 1
- Study location
Study Summary
Benign Paroxysmal Positional Vertigo (BPPV) is a common complaint of emergency department patients. The importance of early diagnosis and treatment can lead to a much improved quality of life for patients afflicted by this ailment. It is the purpose of this study to evaluate and examine two methods of treatment. Patients will be randomized to receive the more common conventional medication therapy versus the canalith repositioning technique. All patients enrolled into this study are emergency department patients who have been diagnosed with BPPV via a positive Dix-Hallpike Maneuver. The hypothesis of this study is that vestibular rehabilitation will allow for resolution of symptoms without the use of conventional medication therapy in the acute management of BPPV in the emergency department patient.
Primary Outcome
The Likert Scale measured patient satisfaction on a 0-10 score range (0 = Least Satisfied; 10 = Most Satisfied).
Conditions Studied
Interventions
- DRUG Ondansetron
- DRUG Diphenhydramine
- DRUG Lorazepam
- DRUG Meclizine
- OTHER Epley Maneuver
Study Locations (1)
Pennsylvania
- Lehigh Valley Hospital - Allentown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2006-11 |
| Est. Completion | 2013-11 |
| Phase | NA |
What the finished NCT00641797 record still lists
NCT00641797 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 26 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Benign Paroxysmal Positional Vertigo appearing as the primary indexed condition, and to 5 interventions - of which Ondansetron is the first listed.
NCT00641797 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT00641797 about?
NCT00641797 is a clinical study titled "Treating Benign Paroxysmal Positional Vertigo (BPPV) in ED Patients". Benign Paroxysmal Positional Vertigo (BPPV) is a common complaint of emergency department patients. The importance of early diagnosis and treatment can lead to a much improved quality of life for patients afflicted by this ailment. It is the purpose of this study to evaluate and examine two methods ...
What is the current status of trial NCT00641797?
This trial is currently completed. It is a NA study. The enrollment target is 26 participants. The study started on 2006-11. Estimated completion is 2013-11.
What conditions does trial NCT00641797 study?
This clinical trial studies the following conditions: Benign Paroxysmal Positional Vertigo.
What interventions are being tested in trial NCT00641797?
The interventions under investigation include: Ondansetron (DRUG), Diphenhydramine (DRUG), Lorazepam (DRUG), Meclizine (DRUG), Epley Maneuver (OTHER).
Who is sponsoring clinical trial NCT00641797?
This trial is sponsored by Lehigh Valley Hospital, which has 16 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00641797 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00641797's enrollment target sits among peer trials
26 1710th of 2000 higher than 289 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02646475 · 26 participants · Phase 1
Metabolic Effects of Angiotensin-(1-7)
- NCT03603223 · 26 participants · Phase 2
Pembrolizumab in Treating Participants With Leukoplakia
- NCT04063592 · 26 participants · NA
AMI Construction in Lower Extremity Residual Limbs
- NCT04906460 · 26 participants · Phase 1
Open-label Study of WVE-N531 in Patients With Duchenne Muscular Dystrophy (FORWARD-53)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia